These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11668978)

  • 21. Public-private partnerships: an overview.
    Widdus R
    Trans R Soc Trop Med Hyg; 2005 Oct; 99 Suppl 1():S1-8. PubMed ID: 16085172
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of university technology transfer operations in assuring access to medicines and vaccines in developing countries.
    Nelsen L
    Yale J Health Policy Law Ethics; 2003; 3(2):301-8. PubMed ID: 14577146
    [No Abstract]   [Full Text] [Related]  

  • 23. More drugs, less protection.
    Nature; 2002 Sep; 419(6904):233. PubMed ID: 12239521
    [No Abstract]   [Full Text] [Related]  

  • 24. The great medicines scandal: access is not just about cost.
    Waning BJ
    BMJ; 2006 Jul; 333(7557):44. PubMed ID: 16809717
    [No Abstract]   [Full Text] [Related]  

  • 25. Building a medicine bank for Venezuela. AIDS treatment access.
    AIDSlink; 1997; (43):5. PubMed ID: 12321757
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NIH forges R&D partnerships in developing countries.
    Salicrup LA
    Nat Biotechnol; 2007 Sep; 25(9):976-7. PubMed ID: 17846621
    [No Abstract]   [Full Text] [Related]  

  • 27. Playing God? Owning God?--Patenting and the human genome.
    Kirby M
    Univ N S W Law J; 2003; 26(3):770-81. PubMed ID: 16617531
    [No Abstract]   [Full Text] [Related]  

  • 28. Access to treatment in developing countries: a global issue of equity and human rights.
    Thomas J
    AIDS Anal Afr; 1998 Apr; 8(2):10-1, 15. PubMed ID: 12293619
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spurious and counterfeit drugs: a growing industry in the developing world.
    Gautam CS; Utreja A; Singal GL
    Postgrad Med J; 2009 May; 85(1003):251-6. PubMed ID: 19520877
    [TBL] [Abstract][Full Text] [Related]  

  • 30. U.S. is lone holdout on drug access vote.
    AIDS Policy Law; 2003 Jan; 18(1):1. PubMed ID: 12569860
    [No Abstract]   [Full Text] [Related]  

  • 31. Implications of bilateral free trade agreements on access to medicines.
    Correa CM
    Bull World Health Organ; 2006 May; 84(5):399-404. PubMed ID: 16710551
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deterring the importation of counterfeit pharmaceutical products.
    Stearn DW
    Food Drug Law J; 2004; 59(4):537-61. PubMed ID: 15875351
    [No Abstract]   [Full Text] [Related]  

  • 33. The responsibility of research universities to promote access to essential medicines.
    't Hoen EF
    Yale J Health Policy Law Ethics; 2003; 3(2):293-300. PubMed ID: 14577145
    [No Abstract]   [Full Text] [Related]  

  • 34. U.S. helps developing countries devise, upgrade EMS systems.
    Tannenhaus N
    Emerg Dep News; 1984 Sep; 6(9):3, 9. PubMed ID: 10267712
    [No Abstract]   [Full Text] [Related]  

  • 35. Uzbekistan drug airlift: a quantitative analysis of public/private collaboration.
    Wertheimer AI; Santella TM; Arroyave VM
    Pharm World Sci; 2005 Aug; 27(4):344-50. PubMed ID: 16228635
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The fight against counterfeit medicines in Africa: experience and role of pharmacists].
    Chauvé M
    C R Biol; 2008 Dec; 331(12):982-5. PubMed ID: 19027699
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Counterfeiting and piracy of pharmaceuticals.
    Grackin A
    IEEE Eng Med Biol Mag; 2008; 27(6):66-9. PubMed ID: 19004698
    [No Abstract]   [Full Text] [Related]  

  • 38. UK leads initiative to drive down cost of drugs in poor countries.
    Short R
    BMJ; 2007 Apr; 334(7599):870. PubMed ID: 17463440
    [No Abstract]   [Full Text] [Related]  

  • 39. Cairo Conference, foreign aid overhaul heighten U.S. pop program visibility.
    Wash Memo Alan Guttmacher Inst; 1994 Jan; (2):1-2. PubMed ID: 12318674
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Promoting public health and protecting consumers in a global economy: an overview of HHS/FDA's international activities.
    Kelly DP; Bachorik LL
    Food Drug Law J; 2005; 60(3):339-46. PubMed ID: 16304741
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.